ArticleLeukemia2015
Early assessment of minimal residual disease in AML by flow cytometry during aplasia identifies patients at increased risk of relapse.
T Köhnke et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
29 papers cite it
this paperpooled itcites it